ROYCE & ASSOCIATES LP - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 204 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,620,318
+47.2%
353,104
+20.2%
0.10%
+55.6%
Q2 2023$6,535,737
-1.5%
293,741
-4.1%
0.06%
-4.5%
Q1 2023$6,633,462
+25.9%
306,254
+18.0%
0.07%
+20.0%
Q4 2022$5,269,917
-24.6%
259,474
-4.9%
0.06%
-30.4%
Q3 2022$6,992,000
+4.8%
272,713
-2.8%
0.08%
+14.5%
Q2 2022$6,669,000
+5.6%
280,450
+0.0%
0.07%
+27.8%
Q1 2022$6,314,000
+503.1%
280,381
+430.0%
0.05%
+575.0%
Q4 2021$1,047,000
+6.7%
52,904
+6.1%
0.01%
+14.3%
Q3 2021$981,000
-14.5%
49,863
-4.4%
0.01%
-12.5%
Q2 2021$1,148,000
-8.0%
52,173
-0.5%
0.01%0.0%
Q1 2021$1,248,000
-22.0%
52,443
-14.3%
0.01%
-38.5%
Q4 2020$1,601,000
+46.7%
61,203
-2.4%
0.01%
+8.3%
Q3 2020$1,091,000
+2.5%
62,706
-0.9%
0.01%0.0%
Q2 2020$1,064,000
+36.8%
63,276
-3.3%
0.01%
+9.1%
Q1 2020$778,000
-3.6%
65,441
-1.9%
0.01%
+57.1%
Q4 2019$807,000
-4.5%
66,712
+11.6%
0.01%
-12.5%
Q3 2019$845,000
+92.0%
59,797
+51.4%
0.01%
+100.0%
Q2 2019$440,000
+67.3%
39,499
+76.3%
0.00%
+100.0%
Q1 2019$263,000
+1447.1%
22,406
+1696.8%
0.00%
Q4 2018$17,000
-26.1%
1,247
-22.9%
0.00%
Q3 2018$23,000
+91.7%
1,618
+116.6%
0.00%
Q2 2018$12,0007470.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders